GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » OncoCyte Corp (STU:7OC0) » Definitions » Other Current Liabilities

OncoCyte (STU:7OC0) Other Current Liabilities : €3.68 Mil (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is OncoCyte Other Current Liabilities?

OncoCyte's other current liabilities for the quarter that ended in Dec. 2023 was €3.68 Mil.

OncoCyte's quarterly other current liabilities increased from Jun. 2023 (€3.46 Mil) to Sep. 2023 (€3.87 Mil) but then declined from Sep. 2023 (€3.87 Mil) to Dec. 2023 (€3.68 Mil).

OncoCyte's annual other current liabilities declined from Dec. 2021 (€5.93 Mil) to Dec. 2022 (€5.75 Mil) and declined from Dec. 2022 (€5.75 Mil) to Dec. 2023 (€3.68 Mil).


OncoCyte Other Current Liabilities Historical Data

The historical data trend for OncoCyte's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoCyte Other Current Liabilities Chart

OncoCyte Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

OncoCyte Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

OncoCyte Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


OncoCyte Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of OncoCyte's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


OncoCyte (STU:7OC0) Business Description

Traded in Other Exchanges
Address
15 Cushing, Irvine, CA, USA, 92618
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through the United States.

OncoCyte (STU:7OC0) Headlines

No Headlines